Anrotinib generally refers to Anrotinib Hydrochloride Capsules, which may be useful for the treatment of pancreatic cancer, but the efficacy may not be ideal, and it is recommended to follow the doctor’s instructions. Anrotinib hydrochloride capsule is a kind of antitumor drug, which is commonly used in the clinic to treat patients with locally advanced or metastatic non-small cell lung cancer, adenovascular soft tissue sarcoma, clear cell sarcoma, and small cell lung cancer. In the clinic may also be applied to patients with advanced pancreatic cancer, because pancreatic cancer is not an indication for Anrotinib, and not as the drug of choice, for pancreatic cancer the specific efficacy of the drug is also not clear at present, there may be a certain role, or the effect may not be ideal. After use may have fatigue, loss of appetite, headache, hypertension and other adverse reactions, patients should follow the doctor’s instructions in accordance with the dosage, to observe the effect of the drug during the period of taking, always communicate with the doctor.